I'm doing well and trying to focus on what's objectively available and discard all the subjective speculations that are circling around on HC - by down rampers, pumpers and scientific nerds alike.
I expect the SP to rebound fairly quickly once the sales revenue start coming in, and think that the low of $1.92 after FDA approval was a joke primarily caused by shorters manipulation, who will find great difficulty in closing their position once the commercial figures drop.
I am over invested for a reason - I see much too great potential in this company that are yet to be fully unlocked. I don't place unrealistic expectations such as $10.04 by EOFY, and my overinvestment requires following up on daily developments to safely manage my risks vs returns.
Frankly, I'm not sure what aspect in my post prompted you to check in on my wellbeing.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)